Index

A

  1. Action on Smoking and Health (ASH) England *, *
  2. alcohol *-*, *, *, *, *, *, *, *, *
  3. American Cancer Society (ACS) *, *, *
  4. American Psychiatric Association *, *, *
  5. amphetamines *, *
  6. anecdotes about quitting *, *-*
  7. assisted quitting *-*, *-*, *, *, *, *
  8. Australian Institute of Health and Welfare (AIHW) *, *, *
    1. AIHW National Drug Household Study 2019 *

B

  1. Baden-Powell, Robert *
  2. Barthes, Roland *
  3. Bates, Clive *, *, *
  4. Beaglehole, Robert *
  5. beliefs about quitting and personal responsibility *, *-*, *
  6. Benowitz, Neil *, *
  7. Bevins, John *
  8. Biernacki, Patrick *, *-*
  9. Bittoun, Rene *-*
  10. blindness integrity in trials *, *-*
  11. Borland, Ron *, *-*, *, *, *-*
  12. Brandt, Alan *
  13. Brereton, Laurie *
  14. brief interventions *, *, *, *, *
  15. British American Tobacco (BAT) *, *, *
  16. British American Tobacco Australia (BATA) *
  17. British Household Panel Survey *
  18. Britton, John *, *, *
  19. bupropion *, *, *, *, *-*, *, *, *, *, *, *, *, *, *

C

  1. Cambodia *
  2. Canada *, *, *, *, *, *, *, *, *, *, *, *
  3. Cancer Council Victoria *-*, *-*
  4. Cancer Institute NSW *
  5. cannabis *, *-*, *
  6. catastrophe theory *
  7. cessation see quit attempts
  8. Champix see varenicline
  9. China *, *
  10. Choice magazine *
  11. citation bias *-*
  12. Clarke, Chris *-*
  13. cocaine *, *, *
  14. Cochrane Collaboration *, *, *, *, *, *, *, *, *, *
  15. cohort studies *, *, *, *-*, *-*, *, *, *, *, *-*, *, *, *-*, *, *
  16. commitment to quitting *, *, *-*, *-*
  17. common liability theory *-*
  18. Commonwealth Scientific and Industrial Research Organisation (CSIRO) *
  19. competing interest bias *-*, *
  20. concepts central to self-quitting *-*, *-*
  21. consumer safety criteria and tobacco *
  22. contingency payments *
  23. cross-sectional surveys *-*, *, *, *, *
  24. cysteine *

D

  1. Daube, Mike *
  2. difficulty in quitting *, *, *-*
  3. Doll, Richard *, *
  4. dominance of interventionism *-*, *, *
  5. “don’t quit – switch” *, *, *-*
  6. Doron, Gideon *
  7. dual use (smoking and vaping) *, *-*, *, *, *, *, *-*, *
  8. Durante, Nicandro *, *

E

  1. e-cigarettes (ECs) see vaping
  2. efficacy vs effectiveness *, *
  3. electronic cigarettes (ECs) see vaping
  4. endgame for combustible tobacco *-*
  5. English quit smoking services *-*, *, *
  6. ethics of scare messaging *-*
  7. ethics of tobacco control *, *
  8. Europe, cessation in *, *
  9. EVALI *
  10. evidence-based cessation *, *, *, *, *

F

  1. Fagerström, Karl *, *
  2. Fairness Doctrine USA *-*
  3. Fiore, Michael *-*
  4. Flavor and Extracts Manufacturing Association USA *-*
  5. flavours and vaping *, *-*, *
  6. folk remedies for quitting *, *-*
  7. Framework Convention on Tobacco Control (FCTC) *, *, *, *
  8. Freeman, Becky *, *, *, *, *, *, *

G

  1. Gallup poll USA *
  2. gambling *-*
  3. gateway hypothesis *-*
  4. general practitioners and cessation *, *-*
  5. GlaxoSmithKline Nicabate promotion *-*
  6. Goffman, Erving *, *
  7. Gray, Nigel *, *, *

H

  1. hardening hypothesis *, *-*, *
  2. Hart, Julian Tudor *
  3. Hawthorne effects *-*
  4. health concerns and quitting, importance of *, *
  5. health consequences of vaping *-*, *, *
  6. heated tobacco products (HTP) *, *, *, *; see also vaping
  7. Heaviness of Smoking Index (HSI) *, *
  8. Henningfield, Jack *
  9. heroin *-*, *
  10. Hill, David *, *
  11. Horn, Daniel *
  12. Hughes, Hollie *, *
  13. Hughes, John *, *, *, *, *, *, *

I

  1. Illich, Ivan *, *
  2. illicit tobacco trade (ITT) *-*
  3. impact of cessation medication a population level *-*
  4. indication bias *-*, *, *, *
  5. Indonesia *, *-*
  6. information campaigns *, *, *, *, *, *, *, *, *
  7. inhalation frequency, smoking vs. vaping *, *-*
  8. intention to treat analysis *-*
  9. Israel *

J

  1. Japan *
  2. Japan Tobacco International (JTI) *

K

  1. Klingemann, Harald *, *, *

L

  1. Larabie, Lynn *
  2. laser acupuncture *, *-*
  3. lay knowledge about quitting *, *, *, *
  4. Le Houezac, Jacques *
  5. Lévi-Strauss, Claude *
  6. Leymore, Varda Langholz *
  7. licensing
    1. limits on number of cigarettes sold *
    2. loss of retail licence *
    3. smokers *-*
    4. tobacco retailers *-*, *-*, *, *
  8. longitudinal cohort studies see cohort studies
  9. loss to follow-up *, *
  10. low income nations *-*, *-*, *
  11. lung cancer *, *

M

  1. Malone, Ruth *
  2. marijuana see cannabis
  3. maturing out *-*
  4. Mayer, Henry *
  5. McKay, Bernie *
  6. McNeill, Ann *, *, *
  7. mechanisation of cigarette production *-*, *, *
  8. medication in smoking cessation *, *, *, *, *-*, *-*, *, *, *, *, *, *
  9. mental health and smoking *, *
  10. meta-analysis *, *, *-*, *, *, *
  11. Millennium Cohort Study UK *
  12. miracle smoking cures *
  13. motivation to quit *, *, *-*, *-*, *
  14. Mãori smoking cessation *, *

N

  1. narcotics see opiates
  2. National Academies of Science, Engineering and Medicine (NASEM) USA *, *
  3. National Health and Medical Research Council (Australia) (NHMRC) *, *
  4. National Institutes of Health, USA (NIH) *
  5. New Zealand *, *, *, *-*, *
  6. news coverage of tobacco control *, *-*, *, *-*
  7. next generation products (NGP) *
  8. nicotine *, *, *, *, *, *, *, *, *
  9. nicotine addiction *, *, *, *, *, *, *, *, *
  10. nicotine replacement therapy (NRT) *, *, *-*, *-*, *, *, *, *, *, *-*, *-*, *, *, *
    1. NRT in Australia *-*, *
    2. promotions *-*
  11. nicotine vaping products (NVP) see vaping
  12. North American Quitline Consortium *
  13. Nutt, David *, *

O

  1. Ochsner, Alton *
  2. Office of Population Censuses and Surveys (UK) *
  3. online quit interventions *, *, *
  4. opiates *-*

P

  1. pack warnings *, *, *, *, *, *, *, *, *, *
  2. Papua New Guinea (PNG) *
  3. PATH (US Population Assessment of Tobacco and Health) cohort study *-*, *, *, *, *-*, *, *
  4. Pavlov, Ivan *
  5. Peele, Stanton *, *, *-*
  6. Peters, Matthew *, *, *
  7. Pharmaceutical Benefits Scheme (Australia) (PBS) *, *
  8. pharmacists and smoking cessation *, *, *
  9. phasing out combustible tobacco sales *-*
  10. Philip Morris International (PMI) *, *, *, *, *, *, *, *
  11. Pierce, John *
  12. Pinney, John *
  13. plain tobacco packs *, *, *, *, *-*, *, *
  14. pleasure and smoking *-*
  15. population focus *, *, *, *-*, *, *, *, *, *, *, *, *
  16. positive outcome bias *-*
  17. prescription access to NVPs *, *, *, *-*, *-*
  18. primary and secondary prevention of smoking *-*
  19. problem gambling see gambling
  20. Prochaska, Judith *
  21. proximal and distal influences on quitting *, *, *-*
  22. public awareness see information campaigns
  23. Public Health England (PHE) *, *, *

Q

  1. qualitative research on smoking cessation *, *-*
  2. quality of evidence pyramid *
  3. quit and win lotteries *-*
  4. Quit. For Life campaign *, *
  5. quit attempts *, *, *, *, *-*, *, *, *, *, *, *, *, *, *, *, *, *, *
    1. importance of *
  6. quit programs run by tobacco companies *
  7. quit smoking clinics *-*, *, *, *, *, *, *
  8. quit smoking services *, *, *, *, *, *-*, *
  9. quitlines *, *, *-*, *
  10. quitting before advent of NRT *, *-*
  11. QALY (Quality Adjusted Life Years) *

R

  1. randomised controlled trials (RCT) *-*, *-*, *, *, *, *-*
  2. real world effectiveness *, *, *
  3. real world use *, *, *, *-*
  4. recall bias *, *-*, *, *
  5. reduced smoking frequency *, *, *
  6. regulation of NVPs, the case for *, *, *, *-*, *-*, *
  7. regulation of other goods and services *, *, *
  8. regulation of pharmaceutical retailing *, *
  9. relapse in cessation *, *, *-*, *, *, *, *, *
  10. Roxon, Nicola *
  11. rule of rescue *
  12. Russell, Michael *, *, *

S

  1. salbutamol inhalers *, *
  2. scare tactics *-*
  3. schizophrenia and smoking *-*, *
  4. Scollo, Michelle *
  5. scream test *
  6. self-selecting motivated samples *-*, *
  7. self-selection bias *-*, *
  8. Senate Enquiry into Tobacco Harm Reduction 2019 *, *, *, *
  9. Seventh Day Adventist church 5-Day Plan *, *
  10. Shiffman, Saul *, *, *
  11. silver nitrate *
  12. SimSmoke simulation model *
  13. Smith, Andrea *, *, *
  14. Smith, Elizabeth *
  15. smokers’ agency *, *, *, *
  16. smokers licences see licensing
  17. smoking cessation and vaping *, *, *-*, *, *, *, *, *-*
  18. smoking cessation services see quit smoking services
  19. smoking frequency and reductions in lung cancer *
  20. smoking prevalence and social disadvantage *
  21. smuggling see illicit tobacco trade (ITT)
  22. Sobell, Linda and Mark *, *, *
  23. social desirability effects *, *
  24. Society for Research on Nicotine and Tobacco *
  25. sound bites *
  26. spontaneous unplanned quitting *, *-*
  27. stages of change *, *-*
  28. Stapleton, John *, *, *
  29. stigmatisation *, *, *
  30. success rates vs intervention and policy reach *-*
  31. systematic reviews *, *, *, *, *, *, *, *, *, *, *, *

T

  1. Tanzania *
  2. tax rises as cover for extra retail prices rises *
  3. Thailand *, *, *, *
  4. Therapeutic Goods Administration (Australia) (TGA) *, *, *, *, *, *
  5. tobacco affordability *, *, *, *
  6. tobacco control inputs *
  7. Tobacco Control Scale *, *
  8. tobacco industry investment in NVPs *-*, *, *, *, *
  9. tobacco retailing density, restricting *-*
  10. tobacco supply, controlling *
  11. Tobacco Tactics, University of Bath *
  12. tobacco tax *, *, *, *, *, *, *, *-*, *, *
  13. toxicant exposure with vaping *-*, *, *
  14. trial exclusion criteria *-*
  15. trial participant retention strategies *-*, *

U

  1. unassisted quitting *, *, *, *, *, *, *, *, *, *-*, *, *, *-*, *, *, *, *, *-*, *, *-*, *, *
    1. and the ‘right’ choice *
    2. denigration of *
  2. United States Food and Drug Administration (USFDA) *, *
  3. University of Newcastle, NSW *
  4. upscaled interventions *, *-*

V

  1. Vaillant, George *, *, *
  2. value of NRT market *
  3. value of NVP market *
  4. vaping *-*, *-*
    1. prescription access to *
    2. and smoking frequency *-*, *, *, *-*
  5. varenicline *, *, *, *-*, *, *, *, *, *, *
  6. victim blaming *-*
  7. Vietnam War *

W

  1. Walsh, Raoul *
  2. Warner, Ken *-*, *, *
  3. West, Robert *, *, *, *, *, *
  4. WHO (World Health Organization) *, *, *, *
  5. willpower and quitting *, *, *, *, *
  6. Wodak, Alex *, *
  7. workplace smoking cessation *
  8. Wynder, Ernst *, *, *

Y

  1. youth uptake of vaping *-*, *, *

Z

  1. Zola, Irving *
  2. Zyban see bupropion

ABN: 15 211 513 464
CRICOS number: 00026A

© 2020 Sydney University Press